Optimal protocol of boron neutron captute therapy for malignant melanoma

Optimal protocol of boron neutron captute therapy for malignant melanoma - Optimal protocol of boron neutron captute therapy for malignant melanoma

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000005124

Enrollment

Registered

2011-03-10

Start date

2011-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malignant melanoma

Interventions

Boron neutron capture therapy

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients are not able to receive standard therapy for the disease.

Exclusion criteria

Exclusion criteria: *Having a severe renal disease *Judged as being unsuitable for trial by the doctor

Design outcomes

Primary

Measure	Time frame
Tumor effect and side effect	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026